Long-term risks examined for survivors of adolescent, young adult hematologic cancers
Video: What is mRNA, and how does it work?
21 March 2022ACR updates guidelines for peri-TJA med use in rheumatic disease
21 March 2022Long-term risks examined for survivors of adolescent, young adult hematologic cancers
Survivors of adolescent and young adult (AYA) hematological cancers have anincreased risk of second malignant neoplasms, hospitalizations, and overall mortality, according to a study published online Feb. 25 in Frontiers in Oncology.
